[go: up one dir, main page]

CL2004000575A1 - Compuestos derivados de p-diaminobenceno sustituidos, sus sales; composicion farmaceutica; y su uso como abridores de los canales del ion de la familia kcnq, para tratar enfermedades del sistema nervioso central como desordenes epilepticos, dolor neu - Google Patents

Compuestos derivados de p-diaminobenceno sustituidos, sus sales; composicion farmaceutica; y su uso como abridores de los canales del ion de la familia kcnq, para tratar enfermedades del sistema nervioso central como desordenes epilepticos, dolor neu

Info

Publication number
CL2004000575A1
CL2004000575A1 CL200400575A CL2004000575A CL2004000575A1 CL 2004000575 A1 CL2004000575 A1 CL 2004000575A1 CL 200400575 A CL200400575 A CL 200400575A CL 2004000575 A CL2004000575 A CL 2004000575A CL 2004000575 A1 CL2004000575 A1 CL 2004000575A1
Authority
CL
Chile
Prior art keywords
diaminobenceno
dolor
openers
neu
substitutes
Prior art date
Application number
CL200400575A
Other languages
English (en)
Spanish (es)
Inventor
Nikolay Rottlander Ma Khanzhin
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004000575(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of CL2004000575A1 publication Critical patent/CL2004000575A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200400575A 2003-03-21 2004-03-19 Compuestos derivados de p-diaminobenceno sustituidos, sus sales; composicion farmaceutica; y su uso como abridores de los canales del ion de la familia kcnq, para tratar enfermedades del sistema nervioso central como desordenes epilepticos, dolor neu CL2004000575A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200300441 2003-03-21

Publications (1)

Publication Number Publication Date
CL2004000575A1 true CL2004000575A1 (es) 2005-01-21

Family

ID=58707221

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400575A CL2004000575A1 (es) 2003-03-21 2004-03-19 Compuestos derivados de p-diaminobenceno sustituidos, sus sales; composicion farmaceutica; y su uso como abridores de los canales del ion de la familia kcnq, para tratar enfermedades del sistema nervioso central como desordenes epilepticos, dolor neu

Country Status (9)

Country Link
KR (1) KR20050115919A (is)
CN (1) CN1761464A (is)
AR (1) AR043652A1 (is)
CL (1) CL2004000575A1 (is)
EA (1) EA200501499A1 (is)
IS (1) IS7991A (is)
NZ (1) NZ541945A (is)
UA (1) UA81019C2 (is)
ZA (1) ZA200507183B (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103073455B (zh) * 2011-10-25 2015-08-19 中国科学院上海药物研究所 一类新型的kcnq钾通道激动剂、其制备方法和用途
CN105017085B (zh) 2014-04-28 2018-06-29 中国科学院上海药物研究所 一类kcnq钾通道激动剂、其制备方法和用途
CN108707087B (zh) * 2018-06-29 2020-10-16 河北医科大学 一种4-(对三氟甲基苄基)-3-氟-1,2,4三苯胺衍生物及其药物组合物与用途
KR102643653B1 (ko) * 2020-11-13 2024-03-06 기초과학연구원 신규한 아미노방향족 화합물 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 신경퇴행성 질환의 예방 또는 치료용 약학적 조성물
CN114672483B (zh) * 2022-05-31 2022-09-02 上海百力格生物技术有限公司 超声法核酸探针制备方法
WO2025075467A1 (ko) * 2023-10-06 2025-04-10 기초과학연구원 허혈성 뇌혈관 질환 및 이의 후유증의 치료를 위한 화합물 및 이를 포함하는 조성물

Also Published As

Publication number Publication date
KR20050115919A (ko) 2005-12-08
CN1761464A (zh) 2006-04-19
NZ541945A (en) 2009-02-28
AR043652A1 (es) 2005-08-03
UA81019C2 (en) 2007-11-26
ZA200507183B (en) 2007-03-28
IS7991A (is) 2005-08-18
EA200501499A1 (ru) 2006-02-24

Similar Documents

Publication Publication Date Title
PA8675701A1 (es) Nuevos derivados del fluoreno, composiciones que los contienen y su utilización
ECSP045473A (es) Derivados de 1-(aminoalquil)-3-sulfonilindol y 1-aminoalquil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6
CU23780B7 (es) Compuestos de quinolina heteroaromaticos y su uso como inhibidores de pde10
UY29028A1 (es) Nuevos derivados piperidilo de quinazolina e isoquinolina
UY28750A1 (es) Derivados tetrahidroisoquinolinilo de quinazolina e isoquinolina
CL2007003005A1 (es) Compuestos derivados de [1,6]-naftiridinona, moduladores de la actividad cinasa; composicion farmaceutica que los comprende; y su uso para tratar trastornos proliferativos, inflamatorios, autoinmune, del sistema nervioso central, entre otros.
CR9135A (es) Derivados novedosos pirrolidilo de compuestos heteroaromaticos
CL2004002066A1 (es) Compuestos derivados de quinazolina, sus enantiomeros, diastereomeros, solvatos y sales, inhibidores del receptor tirosina quinasa; composicion farmaceutica; y su uso para tratar enfermedades hiperdegenerativas en mamiferos, tales como cancer, inflam
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
CL2004000257A1 (es) Compuestos heterociclil-3-sulfonilaza-indol o -indazol; su composicion farmaceutica; su procedimiento de preparacion; y su uso en el tratamiento de trastornos por deficit atencional, abstinencia producto de la adiccion a drogas, alcohol o nicotina, e
BRPI0409173A (pt) compostos e composições como inibidores de proteìna quinase
AR002705A1 (es) Un nuevo compuesto de indolina, un proceso para su preparacion y composiciones farmaceuticas que lo contienen.
UY28876A1 (es) Compuestos de morfolina sustituida y composiciones para el tratamiento de trastornos del sistema nervioso central
UY30330A1 (es) Nuevas formas polimorfas de (2s)-(4e)-n-metil-5-(3-(5-isopropoxipiridin)il)-4-penten-2-amina
CR10062A (es) Composiciones y metodos de tratamiento para trastornos del sistema nervioso central
MX2020001261A (es) Compuestos de pirimidina fusionada sustituida y usos de los mismos.
NI202000100A (es) Inhibidores de moléculas pequeñas de la familia de quinasa jak
CR9407A (es) Tetrahidropiridoazepin-8-onas y compuestos relacionados para el tratamiento de la esquizofrenia
CL2007002768A1 (es) Compuestos derivados de quinolin-amina; proceso de preparacion de dichos compuestos; medicamento; y uso para el tratamiento de enfermedades tales como depresion, trastornos de ansiedad, esquizofrenia, agorafobia, dolor, demencia y enfermedad de parki
CL2004000575A1 (es) Compuestos derivados de p-diaminobenceno sustituidos, sus sales; composicion farmaceutica; y su uso como abridores de los canales del ion de la familia kcnq, para tratar enfermedades del sistema nervioso central como desordenes epilepticos, dolor neu
UY27998A1 (es) Piperazinas sustituidas sustituidas heterocíclicas para el tratamiento de la esquizofrenia
WO2004087690A3 (en) Benzimidazole derivatives and their use for modulating the gaba-a receptor complex
PA8567701A1 (es) Agonistas del receptor b3-adrenergico
DK1841433T3 (da) Præparat til behandling af lidelser i centralnervesystemet
PT1853232E (pt) Forma cristalina estável de mesilato de bifeprunox, suas formas de dosagem e métodos para a sua utilização